CGI-1746
CAS: 910232-84-7
Ref. 3D-FC137661
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Product Information
CGI-1746 is a small molecule with potential anti-cancer activity. It is a fluorogenic probe that can be used to assess the viability of prostate cancer cells in vitro. CGI-1746 has also been shown to inhibit the growth of xenograft tumors in mice by inhibiting protein kinase activities and induction of apoptosis. CGI-1746 selectively inhibits HER2+ breast cancer cell growth, but does not affect normal human cells or other types of cancer cells. This drug binds to the carbonyl group of proteins and monoclonal antibodies against this region may be developed as an immunotherapy for HER2+ breast cancer.
Chemical properties
Technical inquiry about: 3D-FC137661 CGI-1746
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
